Radiopharmaceuticals & Targeted Radioligand Therapy Summit

Welcome to The Radiopharmaceuticals & Targeted Radioligand Therapy Summit — The Radiopharmaceuticals & Targeted Radioligand Therapy Summit brings together senior leaders from pharma, biotech, nuclear medicine, radiochemistry, and healthcare to explore the rapid advancements transforming precision oncology.
As targeted radioligand therapies gain momentum across oncology pipelines, the field is experiencing unprecedented growth—driven by breakthroughs in isotope development, novel targeting mechanisms, and increasing clinical success in treating cancers such as prostate, neuroendocrine, and beyond.
However, challenges remain around isotope supply, manufacturing scalability, regulatory pathways, and global infrastructure. This summit is designed as a highly practical, discussion-led forum focused on overcoming these barriers, accelerating clinical development, and enabling broader patient access to next-generation radiopharmaceuticals.